Molecular defects in mastocytosis: KIT and beyond KIT

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Mastocytosis is characterized by activating KIT mutations, with D816V prevalent in adult systemic mastocytosis.
• Pediatric mastocytosis often involves non-D816V KIT mutations in skin-infiltrating mast cells.
• The clinical course and prognosis of systemic mastocytosis (SM) are variable.

Purpose of the Study:

• To investigate the role of additional molecular defects in the progression of systemic mastocytosis.
• To identify novel oncogenic lesions in advanced SM.
• To explore alternative therapeutic strategies for advanced SM based on molecular findings.

Main Methods:

• Genetic analysis of mast cells from patients with various forms of mastocytosis.
• Molecular profiling of advanced systemic mastocytosis cases.
• Correlation of genetic findings with clinical course and prognosis.

Main Results:

• Activating KIT mutations are frequently identified across mastocytosis variants.
• Distinct KIT mutation profiles are observed in adult and pediatric mastocytosis.
• Additional KIT-independent molecular defects and oncogenic lesions are associated with advanced SM and poorer prognosis.

Conclusions:

• KIT mutations are central to mastocytosis pathogenesis.
• KIT-independent genetic alterations contribute to advanced disease progression.
• Identifying these lesions may guide the use of targeted combination therapies and stem cell transplantation in advanced SM.